SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

FORE Biotherapeutics to Present Plixorafenib Data at Oncology Meetings

The company plans to present new clinical and preclinical data on plixorafenib at upcoming oncology medical meetings. The body says the SNO 2026 presentation will include updated long-term efficacy and safety data from a Phase 1/2a study.

Related stories